Product Images Keppra

This appears to be a table showing the percentage of patients taking two different dosages of the medication KEPPRA (1000 mg/day and 3000 mg/day). The table includes three percentages and then shows the percentages for the two groups of patients (N=97 and N=101) taking the respective dosages. There is not enough context to determine what the percentages represent or what condition the medication is being used to treat.*

This appears to be a table or chart with percentages and numbers related to two different dosages of the medication Keppra. However, without more context or information it is difficult to provide a more useful description.*

This text provides data on the percentage of patients in a clinical trial who received either placebo or KEPPRA. The percentage of patients who received KEPPRA was 19.6%, while the percentage who received placebo was 44.6%. The sample sizes for these groups were N=101 and N=7 respectively.*

This text is a medication label for Levitiracetam, which is being sold under the brand name KEPPRA. The label provides instructions to the pharmacist to dispense the medication in a tight, light-resistant container with a package insert for complete dosage recommendations. Patients must be given an accompanying medication guide. The medication should be stored at 25°C with excursions permitted to 15-30°C. The label provides the product details, including PT# CIP70127 and NDC 50474-594-40 for 120 tablets of 250mg strength. KEPPRA is a trademark of UCB S.A., and the product is manufactured in Smyrna, GA, 30080.*

This is a medication label for Levitiracetam tablets, with a recommended storage temperature of 25°C (77°F), stored in a tight and light-resistant container with child-resistant closures. The label instructs pharmacists to include a medication guide with each patient's prescription and to refer to the package insert for complete dosage recommendations. The medication is manufactured for UCB, Inc. in Smyrna, GA and is a registered trademark under the name KEPPRA.*

This text describes instructions for dispensing and storing medication in a container with child-resistant closure. It also provides information about the usual dosage and storage conditions for the medication, as well as the manufacturer's details and trademark. The text also includes a PT number and NDC number which may be useful for identification purposes. It recommends dispensing an accompanying Medication Guide to every patient.*

Usual Dosage: See package insert for complete dosage recommendations. This is a 100mg/mL oral solution of levetiracetam manufactured by V.P for bucs, inc. This medication should be dispensed with an accompanying medication guide to each patient. It comes in a 16 fl oz (473 mL) bottle and the pharmacist should dispense it in a tight, light-resistant container with a child-resistant closure. It must be stored at 25°C with some excursions allowed up to 15-30°C. Keep this and all medications out of the reach of children.*